• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates.

作者信息

Bakay R A, Fiandaca M S, Barrow D L, Schiff A, Collins D C

出版信息

Appl Neurophysiol. 1985;48(1-6):358-61. doi: 10.1159/000101157.

DOI:10.1159/000101157
PMID:3879797
Abstract

A Parkinson-like syndrome was produced in nonhuman primates and successfully reversed through transplantation of heterologous fetal mesencephalic brain tissue. Rigidity and bradykinesia were induced by the chronic administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Once the deficits were fixed, Macaca mulatta with well-developed Parkinson-like behavior received fetal mesencephalic cell preparations stereotactically implanted into multiple sites of the head of the caudate bilaterally. Both animals demonstrated a normalization of CSF L-dopa and significant improvement in observed activity. The neuropathological studies performed 2 months following transplantation demonstrated successful integration of fetal cells in the caudate.

摘要

相似文献

1
Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates.
Appl Neurophysiol. 1985;48(1-6):358-61. doi: 10.1159/000101157.
2
Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation.
Ann N Y Acad Sci. 1987;495:623-40. doi: 10.1111/j.1749-6632.1987.tb23705.x.
3
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies.
J Neurosurg. 1990 Feb;72(2):231-44. doi: 10.3171/jns.1990.72.2.0231.
4
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).对两名因1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱发帕金森症的患者进行双侧胎儿中脑移植。
N Engl J Med. 1992 Nov 26;327(22):1556-63. doi: 10.1056/NEJM199211263272203.
5
Tissue grafting and immunosuppression.组织移植与免疫抑制。
J Neurosurg. 1991 Jan;74(1):157-9. doi: 10.3171/jns.1991.74.1.0157.
6
Fifteen months' follow-up on bilateral embryonic mesencephalic grafts in two cases of severe MPTP-induced parkinsonism.对两例严重MPTP诱导的帕金森病患者双侧胚胎中脑移植进行15个月的随访。
Adv Neurol. 1993;60:729-33.
7
Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
Brain Res. 1998 Jun 8;795(1-2):55-62. doi: 10.1016/s0006-8993(98)00252-2.
8
Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies.
J Neurosurg. 1991 Jan;74(1):97-104. doi: 10.3171/jns.1991.74.1.0097.
9
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.1-甲基-4-苯基-1,2,3,6-四氢吡啶对猴和人的神经毒性
Can J Neurol Sci. 1984 Feb;11(1 Suppl):166-8. doi: 10.1017/s0317167100046345.
10
Parkinson-like syndrome in nonhuman primates receiving a tetrahydropyridine derivative.接受四氢吡啶衍生物的非人类灵长类动物中的帕金森样综合征。
Neurotoxicology. 1986 Spring;7(1):119-26.

引用本文的文献

1
Defining the unknowns for cell therapies in Parkinson's disease.定义帕金森病细胞疗法的未知因素。
Dis Model Mech. 2022 Oct 1;15(10). doi: 10.1242/dmm.049543. Epub 2022 Sep 27.
2
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson's and Huntington's Disease.治疗运动障碍的正确轨道:帕金森病和亨廷顿病的有前景的治疗方法
Front Aging Neurosci. 2020 Sep 3;12:571185. doi: 10.3389/fnagi.2020.571185. eCollection 2020.
3
Studies in neurobiology and aging at the United States National Institutes of health-sponsored regional primate research centers.
美国国立卫生研究院资助的区域灵长类动物研究中心开展的神经生物学与衰老研究。
Am J Primatol. 1994;34(1):41-50. doi: 10.1002/ajp.1350340109.
4
Cell therapy for Parkinson's disease: Why it doesn't work every time.细胞疗法治疗帕金森病:为何并非每次都有效。
Mov Disord. 2019 Aug;34(8):1120-1127. doi: 10.1002/mds.27742. Epub 2019 Jun 24.
5
Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.人原代多巴胺能神经元移植与诱导多能干细胞衍生的多巴胺能神经元移植在帕金森病大鼠模型中的比较
Stem Cell Rev Rep. 2016 Feb;12(1):105-20. doi: 10.1007/s12015-015-9623-7.
6
Cell based therapies in Parkinson's Disease.帕金森病的细胞治疗
Ann Neurosci. 2011 Apr;18(2):76-83. doi: 10.5214/ans.0972.7531.1118209.
7
The immunological challenges of cell transplantation for the treatment of Parkinson's disease.细胞移植治疗帕金森病的免疫学挑战。
Brain Res Bull. 2012 Jul 1;88(4):320-31. doi: 10.1016/j.brainresbull.2012.03.001. Epub 2012 Apr 11.
8
Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.帕金森病的多巴胺细胞移植:对照临床试验的重要性。
Neurotherapeutics. 2011 Oct;8(4):549-61. doi: 10.1007/s13311-011-0082-9.
9
Preclinical assessment of stem cell therapies for neurological diseases.用于神经疾病的干细胞疗法的临床前评估。
ILAR J. 2009;51(1):24-41. doi: 10.1093/ilar.51.1.24.
10
Cell-based therapies for Parkinson's disease: past, present, and future.基于细胞的帕金森病疗法:过去、现在和未来。
Antioxid Redox Signal. 2009 Sep;11(9):2189-208. doi: 10.1089/ars.2009.2654.